A round burgundy crest emblem with simple gold ring detailing, plain and formal in style
A wide horizontal photograph of mountain scenery near Banff with pale turquoise sky, dark evergreen slopes, and a soft muted mood
A round burgundy crest emblem mirroring the first, with plain gold ring detailing and a formal quiet mood

Annual Scientific Meeting of the Canadian Organization of Medical Physicists — July 9–12, 2014, The Banff Centre, Banff, Alberta, Canada


Comparing Film and Array Detectors for IMRT Quality Assurance

Intensity-modulated radiation therapy has reshaped cancer care across Australian cancer centres, with departments in Sydney, Melbourne, and Brisbane routinely delivering tightly conformed doses to complex target volumes. The success of these treatments depends on rigorous quality assurance programmes that catch delivery errors before they reach the patient. Detector selection sits at the heart of those programmes.

Two detector families dominate the conversation: radiographic film and modern electronic array detectors. Both approaches have earned their place in modern medical physics, yet each behaves differently when measuring steep dose gradients, small field segments, and time-sensitive clinical workflows. Understanding those differences helps physics teams pick the right tool and build a defensible quality programme.

Why Detector Choice Shapes Modern Radiotherapy Quality Assurance

The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) sets the regulatory framework that governs how linear accelerators are commissioned and monitored. Within that framework, the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) issues professional standards and training pathways that shape detector selection in departments from Perth to Adelaide. Choosing a dosimeter is rarely a purely technical question; it also touches on staffing, turnaround time, and audit defensibility.

Array detectors offer rapid electronic readout, while film provides a high-resolution two-dimensional record that many physicists still trust for the most challenging plans. National funding models such as Activity Based Funding add another layer, pushing departments to maximise fractions delivered per linac hour.

For Australian centres participating in multi-institutional trials coordinated through the Trans-Tasman Radiation Oncology Group, detector choice also affects credentialing. Film and array results are often both required to satisfy protocol-specific tolerance levels for complex plans.

Film Dosimetry in Contemporary Clinical Practice

Radiographic and radiochromic films produce a planar dose map with resolution well below one millimetre, capturing the sharp dose gradients that IMRT fields create near field edges and around beam-modifying structures. In facilities that use EBT3 or EBT-XD film, physicists can spot subtle discrepancies between planned and delivered fluence that array detectors may smooth over. For end-to-end tests of stereotactic plans, film remains a respected verification tool.

The trade-offs are familiar to anyone who has spent a Saturday afternoon in a film darkroom or in front of a flatbed scanner queue. Film requires controlled handling, careful calibration curves, and dedicated processors. In Australian centres operating with lean staffing, those added hours can slow the QA cycle. The labour-intensive nature pushes many departments toward hybrid workflows: film for commissioning, with array detectors handling the daily workload.

Array Detectors: Speed, Signal, and Modern Workflows

Two-dimensional detector arrays, built from ionisation chambers or solid-state diodes, provide near-instant readouts that slot into the busy rhythm of a radiotherapy department. With software tools such as SNC Patient or Compass, physicists can compare measured and calculated dose distributions within minutes and produce reports that satisfy audit requirements from the Royal Australian and New Zealand College of Radiologists. The Australian Nuclear Science and Technology Organisation (ANSTO), based at Lucas Heights, has supported the development and characterisation of dosimetric phantoms that pair with these detectors.

Modern arrays offer 2D sampling that captures most clinically relevant dose patterns. Diode arrays in particular have excellent dose-rate response and minimal temperature dependence, which suits them to the rapid linac schedules common in public hospitals across Queensland and New South Wales. The catch is sampling density: a typical detector grid samples every five to seven millimetres, leaving small-field errors for film or specialised high-resolution arrays to catch.

Sensitivity, Spatial Resolution, and Measurement Uncertainty

When physicists compare the two approaches, they rarely argue over a single number. A useful picture emerges from a small set of practical metrics that can be tracked side by side across detectors. Vendors quote their headline numbers, but the live values in your own clinic depend on calibration, linac pulse rate, and the patient plans you deliver most often.

These figures shift with manufacturer, model, and protocol, yet they offer a useful starting point when reviewing vendor specifications and writing departmental procedures. Departments undertaking tighter audits for clinical trials often run film checks at regular intervals to back up array results and document long-term consistency for credentialing bodies.

Metrics worth tracking

  • Spatial resolution below 1 mm for radiochromic film versus 5–7 mm sampling for standard 2D arrays.
  • Dose uncertainty often quoted near ±3 percent for film with proper calibration, contrasted with ±1–2 percent for ion chamber arrays.
  • Sensitivity to volume-averaging effects in steep dose gradients, where arrays can under-respond by 5 percent or more.
  • Stability over a QA session, with film responding primarily to processing conditions and arrays responding to temperature drift and linac pulse rate.

Workflow Integration in Busy Cancer Centres

The Queensland climate and the long radiotherapy rosters at centres such as Royal Brisbane and Women's Hospital illustrate how detector choice intersects with daily schedule. A typical IMRT plan verification using an array system can be measured, analysed, and signed off within thirty minutes, freeing the linac for the next patient. A film-based verification typically consumes most of an afternoon when scanner time, calibration, and analysis are factored in. The trade-off matters when departmental throughput is funded per fraction under Activity Based Funding arrangements.

Conference attendees planning their visit will want to consult the conference programme to see which sessions address measurement uncertainty and complex plan verification. Comparing how other centres structure their detector mix can help physicists from Christchurch to Cairns refine their own protocols when they return home.

Building a Hybrid Detector Programme

Choosing between film and array detectors rarely means choosing just one. Australian centres often combine both: arrays handle daily linac QA and standard IMRT plan checks, while film supports commissioning and complex plan verification. The right balance depends on case mix, staffing, and the expectations of external auditors.

When designing or reviewing a quality programme, the team should match detector performance to the most demanding plans it delivers. A department running many stereotactic cases needs finer resolution than one focused on simple tangents.

Delegates looking to extend their stay can explore the practical accommodation choices and arrive a day early to join vendor workshops before the main programme begins.

Practical implementation steps

  • Catalogue the IMRT plan complexity that the department delivers most often.
  • Match detector spatial sampling to the smallest clinically relevant field segment.
  • Reserve film for cases where gradients exceed array resolution limits.
  • Schedule periodic cross-checks between array and film to catch systematic drift.
  • Document detector choice and tolerances in line with ACPSEM and ARPANSA expectations.

The recognition of long service and lifetime contributions celebrated at the-annual-banquet-a-celebration-of-awards-and-achievements also offered valuable informal conversations on detector evaluation and QA programme design across practice settings. Many attendees carried new ideas home to their Australian clinics, where staffing realities and reimbursement structures continue to shape detector choices.

If you are weighing an upgrade or building a new IMRT quality programme, take the time to publish your detector comparison data and bring it to the next meeting for a richer on-stage discussion.